What is Octave Bioscience worth?
$143.0Mlast known valuation
Octave Bioscience last raised $31.8M in its Early Stage VC (Mar 2025).
Free account
See the evidence behind this price
- ·Post-money valuations for all 5 rounds
- ·The complete investor list — 18 names
- ·Watchlist + deal alerts for Octave Bioscience
Create free account
No card required
Funding history
5 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Mar 2025 | Early Stage VC | $31.8M | ▮ | ▮ |
| Sep 2023 | Early Stage VC | $7.0M | ▮ | ▮ |
| Jan 2023 | Early Stage VC | $32.5M | ▮ | ▮ |
| Oct 2020 | Early Stage VC | $32.0M | ▮ | ▮ |
| Nov 2014 | Seed Round | $2.5M | ▮ | ▮ |
How Octave Bioscience's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Octave Bioscience, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Octave Bioscience worth?
- Octave Bioscience's last known valuation is $143.0M.
- How much has Octave Bioscience raised?
- Octave Bioscience has raised $129.2M in total funding across 5 recorded rounds.
- When did Octave Bioscience last raise?
- Octave Bioscience last raised in Mar 2025 (Early Stage VC), raising $31.8M.